FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37531111000001103: Dolutegravir 50mg / Lamivudine 300mg tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
351001000001115 Dolutegravir 50mg / Lamivudine 300mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
351021000001110 Dolutegravir 50mg / Lamivudine 300mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolutegravir 50mg / Lamivudine 300mg tablets Is a Lamivudine + Dolutegravir true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Is a Lamivudine + Dolutegravir false Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dolutegravir true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Has specific active ingredient Lamivudine true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Has specific active ingredient Dolutegravir sodium true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Plays role Antiretroviral therapeutic role true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Dolutegravir 50mg / Lamivudine 300mg tablets 30 tablet Has VMP True Dolutegravir 50mg / Lamivudine 300mg tablets Inferred relationship Existential restriction modifier
Dovato 50mg/300mg tablets (ViiV Healthcare UK Ltd) Is a True Dolutegravir 50mg / Lamivudine 300mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start